Robert Habib is the founder of MiNA Therapeutics. MiNA Therapeutics has raised $45M in total funding. Latest round: Series A. Backed by Eli Lilly.
Robert Habib is the CEO of MiNA Therapeutics, a London-based biotechnology company that focuses on pioneering first-in-class activating RNA therapeutics for cancer treatment. He has guided the company through milestones including securing Series A financing and an equity investment from Eli Lilly.
Full founder directory · Investor directory · Company funding database · Fundraising library